BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270
19 results:

  • 1. Surgical removal of FIGO type 0 and 1 fibroids ameliorates the expression of endometrial proinflammatory transcription factors and receptivity modulators.
    Dokuzeylül Güngör N; Önal M; Madenli AA; Ağar M
    Fertil Steril; 2023 Mar; 119(3):504-513. PubMed ID: 36473610
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.
    Ding L; Bi Z; Wu J; Zhu J; Yu Y; Yao HR; Liu YM
    Arch Gynecol Obstet; 2023 Mar; 307(3):891-901. PubMed ID: 35708782
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combined expression of hoxa11 and CD10 identifies endometriosis versus normal tissue and tumors.
    Bergman-Larsson J; Gustafsson S; Méar L; Huvila J; Tolf A; Olovsson M; Pontén F; Edqvist PD
    Ann Diagn Pathol; 2022 Feb; 56():151870. PubMed ID: 34844098
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
    Ge F; Tie W; Zhang J; Zhu Y; Fan Y
    J Clin Lab Anal; 2021 Nov; 35(11):e24015. PubMed ID: 34606634
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Downregulation of hoxa11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
    Kong C; Zhu Z; Li Y; Xue P; Chen L
    Clin Transl Oncol; 2021 Jul; 23(7):1334-1341. PubMed ID: 33515421
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Deregulation of H19 is associated with cervical carcinoma.
    Roychowdhury A; Samadder S; Das P; Mazumder DI; Chatterjee A; Addya S; Mondal R; Roy A; Roychoudhury S; Panda CK
    Genomics; 2020 Jan; 112(1):961-970. PubMed ID: 31229557
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Decreased expression of LIF mRNA in patients withmyoma uteri.
    Kara M; Sabah Ozcan S; Aran T; Kara O; Yilmaz N
    J Cell Biochem; 2019 Mar; 120(3):3423-3427. PubMed ID: 30242886
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of the human female reproductive tract.
    Cunha GR; Robboy SJ; Kurita T; Isaacson D; Shen J; Cao M; Baskin LS
    Differentiation; 2018; 103():46-65. PubMed ID: 30236463
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Response of xenografts of developing human female reproductive tracts to the synthetic estrogen, diethylstilbestrol.
    Cunha GR; Kurita T; Cao M; Shen J; Robboy SJ; Baskin L
    Differentiation; 2017; 98():35-54. PubMed ID: 29102757
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular mechanisms of development of the human fetal female reproductive tract.
    Cunha GR; Kurita T; Cao M; Shen J; Robboy S; Baskin L
    Differentiation; 2017; 97():54-72. PubMed ID: 29053991
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The long noncoding RNA hoxa11 antisense induces tumor progression and stemness maintenance in cervical cancer.
    Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
    Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of Endometrial Receptivity Genes Increase After Myomectomy of Intramural Leiomyomas not Distorting the Endometrial Cavity.
    Unlu C; Celik O; Celik N; Otlu B
    Reprod Sci; 2016 Jan; 23(1):31-41. PubMed ID: 26507873
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
    Awunor O; Berger D; Kirisits C
    Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma.
    Chen J; Fu Z; Ji C; Gu P; Xu P; Yu N; Kan Y; Wu X; Shen R; Shen Y
    Biomed Pharmacother; 2015 May; 72():83-90. PubMed ID: 26054679
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
    Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
    Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity.
    Rackow BW; Taylor HS
    Fertil Steril; 2010 Apr; 93(6):2027-34. PubMed ID: 18555231
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. hoxa11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
    Fiegl H; Windbichler G; Mueller-Holzner E; Goebel G; Lechner M; Jacobs IJ; Widschwendter M
    Int J Cancer; 2008 Aug; 123(3):725-9. PubMed ID: 18478570
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Frequent hoxa11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.
    Whitcomb BP; Mutch DG; Herzog TJ; Rader JS; Gibb RK; Goodfellow PJ
    Clin Cancer Res; 2003 Jun; 9(6):2277-87. PubMed ID: 12796396
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure.
    Li S; Ma L; Chiang T; Burow M; Newbold RR; Negishi M; Barrett JC; McLachlan JA
    Mol Carcinog; 2001 Dec; 32(4):213-9. PubMed ID: 11746833
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.